Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Chinese Herbal Formula Shu Yu Wan in Lung Cancer Patients: a Randomized Double-blind Placebo- Controlled Trial

NCT04615884 is registered in ClinicalTrials.gov with Lady Davis Institute as lead sponsor.

NCT NCT04615884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04615884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Chinese Herbal Formula Shu Yu Wan in Lung Cancer Patients: a Randomized Double-blind Placebo- Controlled Trial
Lead sponsor
Lady Davis Institute
Phase
Not applicable
Overall status
Withdrawn
Start date
March 31, 2022
Completion date
March 31, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic nsclc